Drug attacks genetic roots of breast cancer
An experimental drug tested in Pittsburgh is so effective at treating aggressive forms of breast cancer that doctors say it gives new hope to women battling the disease and represents another powerful weapon to attack cancer at its genetic roots.
Tykerb -- a so-called "smart drug" that targets only tumor cells -- halts the progress of advanced breast cancer in patients who no longer respond to the best-selling drug Herceptin, according to study results to be presented today at the annual meeting of the American Society of Clinical Oncology in Atlanta.
· Read The Full Cancer Article From Pittsburgh Tribune-Review -->
·
Read All Cancer News Stories -->